These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9018811)

  • 1. ADCC activity of monoclonal anti-D antibodies.
    Armstrong-Fisher SS; Gray I; Todd DH; Forrest A; Urbaniak SJ
    Transfus Clin Biol; 1996; 3(6):475-7. PubMed ID: 9018811
    [No Abstract]   [Full Text] [Related]  

  • 2. ADCC activity of monoclonal anti-D antibodies.
    Urbaniak SJ; Stewart GM
    Rev Fr Transfus Immunohematol; 1988 Apr; 31(2):237-43. PubMed ID: 3145551
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization and functional activity of human Rh monoclonal antibodies.
    Kumpel BM; Jackson DJ
    Transfus Clin Biol; 1996; 3(6):453-8. PubMed ID: 9018806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte antibody-dependent cytotoxicity test for evaluation of clinical role of monoclonal anti-D-antibodies for prevention of rhesus sensitization.
    Olovnikova NI; Belkina EV; Nikolaeva TL; Miterev GY; Chertkov IL
    Bull Exp Biol Med; 2006 Jan; 141(1):57-61. PubMed ID: 16929965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of lysis of bromelain and papain treated red cells in ADCC assays.
    Kumpel BM; Bakács T
    Immunol Lett; 1992 Feb; 31(3):237-40. PubMed ID: 1548038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional activity of Rh monoclonal antibodies in ADCC assay.
    Delsalle A; Bendik B; Mannessier L
    Transfus Clin Biol; 1996; 3(6):469-71. PubMed ID: 9018809
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibody-dependent cell-mediated cytotoxicity (ADCC) toward human O+ red cells coated with anti-D antibody: comparison between lymphocyte and monocyte ADCC activity.
    Sunada M; Suzuki S; Ota Z
    Acta Med Okayama; 1985 Apr; 39(2):77-89. PubMed ID: 3923782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Absence of relation between activity of mono- and polyclonal anti-rhesus immunoglobulins in in vitro and in vivo tests].
    Olovnikova NI; Belkina EV; Nikolaeva TL; Chertkov IL
    Biull Eksp Biol Med; 1998 Jan; 125(1):71-4. PubMed ID: 9532373
    [No Abstract]   [Full Text] [Related]  

  • 9. Coordinator's report: an assessment of the functional activity of human Rh monoclonal antibodies after their evaluation by nine laboratories.
    Kumpel BM
    Transfus Clin Biol; 1996; 3(6):439-52. PubMed ID: 9018805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of IgG1 monoclonal anti-Rh(D): an investigation using ADCC and macrophage binding assays.
    Armstrong SS; Wiener E; Garner SF; Urbaniak SJ; Contreras M
    Br J Haematol; 1987 Jun; 66(2):257-62. PubMed ID: 3038161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional (ADCC) study of 54 IgG MAb anti-RhD.
    Brossard Y; Dangu C; Patereau C; Goossens D
    Transfus Clin Biol; 1996; 3(6):459-63. PubMed ID: 9018807
    [No Abstract]   [Full Text] [Related]  

  • 12. Differences between the activities of human monoclonal IgG1 and IgG3 anti-D antibodies of the Rh blood group system in their abilities to mediate effector functions of monocytes.
    Wiener E; Jolliffe VM; Scott HC; Kumpel BM; Thompson KM; Melamed MD; Hughes-Jones NC
    Immunology; 1988 Oct; 65(2):159-63. PubMed ID: 3192267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical evaluation of the ADCC test.
    Brojer E; Górska B
    Arch Immunol Ther Exp (Warsz); 1986; 34(2):231-8. PubMed ID: 3098206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ability of monoclonal anti-D antibodies to promote the binding of red cells to lymphocytes, granulocytes and monocytes.
    Merry AH; Brojer E; Zupanska B; Hadley AG; Kumpel BM; Hughes-Jones NC
    Vox Sang; 1989; 56(1):48-53. PubMed ID: 2492701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of producer cell line on functional activity of anti-D monoclonal antibodies destined for prevention of rhesus sensitization.
    Olovnikova NI; Ershler MA; Belkina EV; Nikolaeva TL; Miterev GY
    Bull Exp Biol Med; 2009 Apr; 147(4):448-52. PubMed ID: 19704946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human mononuclear cell antibody-dependent cell-mediated cytotoxicity toward red blood cells of various Rh genotypes.
    Jabs AD; Okubo K; Okubo K; Yokoyama MM
    Kurume Med J; 1982; 29(4):163-72. PubMed ID: 6821118
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-ganglioside GM2 monoclonal antibody-dependent killing of human lung cancer cells by lymphocytes and monocytes.
    Hanibuchi M; Yano S; Nishioka Y; Yanagawa H; Sone S
    Jpn J Cancer Res; 1996 May; 87(5):497-504. PubMed ID: 8641987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional interactions of aglycosylated monoclonal anti-D with Fc gamma RI+ and Fc gamma RIII+ cells.
    Leader KA; Kumpel BM; Hadley AG; Bradley BA
    Immunology; 1991 Apr; 72(4):481-5. PubMed ID: 1828055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An in-vitro assessment of the functional activity of monoclonal anti-D.
    Hadley AG; Kumpel BM; Leader K; Merry AH; Brojer E; Zupanska B
    Clin Lab Haematol; 1989; 11(1):47-54. PubMed ID: 2495881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional interactions of erythrocytes sensitized by IgG1 (E-IgG1) and IgG3 (E-IgG3) human monoclonal anti-D with monocytes.
    Hadley AG; Kumpel BM
    Biochem Soc Trans; 1990 Apr; 18(2):304-5. PubMed ID: 2116338
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.